Technical Update - Maersk, Novo Nordisk, Vestas Wind and Demant Technical Update - Maersk, Novo Nordisk, Vestas Wind and Demant Technical Update - Maersk, Novo Nordisk, Vestas Wind and Demant

Technical Update - Maersk, Novo Nordisk, Vestas Wind and Demant

Equities 4 minutes to read
Kim Cramer Larsson

Technical Analyst, Saxo Bank

A.P. Møller Maersk share price is heavily linked to the price on containers. Medium-term Maersk got rejected at resistance around 16,000. Trend is down supported by RSI in a downtrend and showing negative sentiment.
Short-term Maersk is trading in a corrective rising channel. It looks like the upside is limited with RSI still showing negative sentiment being rejected at 60 threshold several times by now. If Maersk breaks bearish out of the channel and closes below DKK14,935 the share price is likely to test September lows around 13,185 possibly the strong support area around 12,720-11,885. 
For Maersk to reverse the down trend a close above 16,200 is needed.


Source: Bloomberg
Source: Saxo Group
Source: Saxo Group

Vestas Wind is trading in a medium-term falling trend forming a Wedge like pattern on the weekly time period. If Vestas can break above the upper falling trendline there could be more upside to resistance around DKK200.

Short-term Vestas is at the time of writing accelerating the uptrend breaking out of the slightly rising channel it has been trading in past couple of weeks. A double bottom pattern was formed in early October and a potential target is around 171.60, illustrated by the two vertical arrows. However, the share price could spike up to around 184.
The 55, 100 and 200 SMA’s (Simple Moving Averages) will provide some resistance.

If Vestas closes today back below the upper trend line in the rising channel the uptrend could be in jeopardy.
For Vestas to reverse this uptrend a close below todays low at 171.75 is needed. For Vestas to resume down trend a close below 131.30. If that scenario plays out Vestas could see its share price back to 2020 lows below DKK100.

Source: Saxo Group

Demant A/S is trading significantly lower this morning breaking bearish out of its short-term rising channel. Demant seems to be resuming the down trend the share has been in the past year. Demant is likely to test the support at around DKK174.75 shortly – see weekly chart.

A close below, which is quite likely, could push Demant back to 2020 lows around 134-132. For Demant to reverse the down trend a close above 217 is needed. A close of today’s opening gap would be first indication of this scenario to play out. A quite unlikely scenario it should be noted.
All indicators point to lower share price on Demant. RSI below 40 and no divergence and MACD turning sharply bearish.

Source: Saxo Group
Source: Saxo Group

Novo Nordisk is in an uptrend on short-, medium- and long-term time horizon. 
Opening today above resistance around DKK824 Novo seems set for at test of previous all-time high at 863.60. Daily RSI has bounced off lower rising trend line and is above 60 indicating higher price levels.

A break of 863.60 is in the cards. On Weekly chart Novo seems to be trading in a rising channel and if the upper trend line is to be reached Novo could trade above 900-950.
However, there is divergence on RSI going back to Q4 2021 indicating weakening of the trend, but if weekly RSI closes above the falling trendline and above 60 threshold Novo is set for new highs.
To reverse this medium and long-term uptrend Novo needs to close below 730.

Source: Saxo Group

Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (
- Analysis Disclaimer (
- Notification on Non-Independent Investment Research (

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000

Contact Saxo

Select region


The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.